Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SUPN

Supernus Pharmaceuticals Inc

May 29 • 04:00PM ET

46.18

-0.67 -1.43 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: INDV ALKS AMRX KNSA LNTH NBIX ACAD TLX BIIB VRTX

| Held by: IJR VTI IWM VB VBR VXF SPSM IWN IJT VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	6.15%	Shs Outstand	58.04M	Perf Week	-6.48%
Market Cap	2.68B	Forward P/E	11.73	EPS next Y	3.94	Insider Trans	-5.36%	Shs Float	54.47M	Perf Month	-4.88%
Enterprise Value	2.34B	PEG	0.63	EPS next Q	0.44	Inst Own	99.80%	Short Float	8.69%	Perf Quarter	-15.62%
Income	-29.02M	P/S	3.45	EPS this Y	-23.44%	Inst Trans	1.54%	Short Ratio	7.37	Perf Half Y	0.22%
Sales	776.83M	P/B	2.49	EPS next Y	58.98%	ROA	-2.04%	Short Interest	4.73M	Perf YTD	-7.08%
Book/sh	18.55	P/C	6.98	EPS next 5Y	18.48%	ROE	-2.75%	52W High	59.68 -22.62%	Perf Year	45.77%
Cash/sh	6.62	P/FCF	32.59	EPS past 3/5Y	- -	ROIC	-2.62%	52W Low	30.83 49.79%	Perf 3Y	37.36%
Dividend Est.	-	EV/EBITDA	47.02	Sales past 3/5Y	2.52% 6.68%	Gross Margin	76.89%	Volatility	3.39% 4.10%	Perf 5Y	54.71%
Dividend TTM	-	EV/Sales	3.01	EPS Y/Y TTM	-145.12%	Oper. Margin	-6.13%	ATR (14)	1.81	Perf 10Y	141.15%
Dividend Ex-Date	-	Quick Ratio	1.72	Sales Y/Y TTM	16.29%	Profit Margin	-3.74%	RSI (14)	37.35	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	1.96	EPS Q/Q	81.20%	SMA20	-5.99%	Beta	0.55	Target Price	62.83
Payout	-	Debt/Eq	0.04	Sales Q/Q	38.63%	SMA50	-6.99%	Rel Volume	0.77	Prev Close	46.85
Employees	778	LT Debt/Eq	0.03	Earnings	May 05 AMC	SMA200	-5.64%	Avg Volume	642.23K	Price	46.18
IPO	May 01, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	102.29% 7.67%	Trades		Volume	495,874	Change	-1.43%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)